Market evolution: Electrodiagnostic devices (CN 90181990) — 2015–2025

Introduction

This report examines the trade dynamics of CN code 90181990 — a residual category covering electro-diagnostic apparatus for functional exploratory examination and physiological-parameter checking, excluding electro-cardiographs, ultrasound scanners, MRI systems, scintigraphic apparatus, and multi-parameter monitoring devices. The code thus captures a broad and heterogeneous set of devices including electromyographs (EMG), electroencephalographs (EEG), nerve conduction instruments, evoked-potential systems, and similar specialised equipment.

Over the 2015–2025 period, EU trade in this product category underwent a remarkable transformation. Total extra-EU trade in value grew from roughly €1.3 billion to nearly €6.7 billion, driven by a combination of sustained volume growth, rising unit values, and — most visibly since 2020 — a structural shift that turned the EU from a near-balanced trader into a significant net importer. The overview dashboard provides the full dataset underpinning the analysis below.

1. A Dramatic Expansion Fueled by Both Volume and Price

1.1. Trade values grew at an unprecedented pace

Between 2015 and 2025, EU exports of CN 90181990 rose from €648 million to €2,967 million (+358%), while imports surged from €642 million to €3,731 million (+481%). The asymmetry is significant: import growth outpaced export growth by over 120 percentage points, setting the stage for the trade-balance deterioration discussed in the next section.

1.2. Rising unit values signal a shift toward higher-value devices

The expansion was not driven by volume alone. Export unit values rose from €170,536/t in 2015 to €288,220/t in 2025 (+69%), while import unit values climbed from €147,298/t to €286,556/t (+95%). The convergence of export and import unit prices suggests that the EU's product mix in this category has increasingly moved toward premium, technology-intensive devices — consistent with the broader industry trend toward AI-enabled diagnostic, portable EEG/EMG platforms, and connected health equipment.

1.3. The COVID-19 pandemic was a turning point, not a disruption

Unlike many medical-device subcategories that saw demand spikes during 2020 before reverting to trend, CN 90181990 trade appears to have accelerated continuously through and beyond the pandemic period. The 2020–2021 interval saw a sharp jump in import volumes from the United Kingdom — a price shock of 569% in 2021 — likely connected to post-Brexit supply-chain restructuring and reclassification of trade flows rather than a genuine demand anomaly.

2. From Trade Balance to Trade Deficit: The EU's Growing Import Reliance

2.1. The trade balance swung from near-equilibrium to a €764 million deficit

In 2015, EU exports and imports of electro-diagnostic apparatus were almost exactly balanced, with a modest surplus of €5.3 million. By 2025, imports exceeded exports by €764 million, marking a structural shift in the EU's position in this market. At the peak imbalance — recorded in the most recent year — the net import reliance stood at −17.1%, having previously reached a maximum export surplus intensity of −144.4% in an earlier year.

2.2. The United States became the dominant import source

The single most important factor behind the trade deficit is the explosive growth of EU imports from the United States:

The partner analysis reveals that the United States alone accounts for approximately 78% of the most recent year's extra-EU imports by value. This extreme concentration is reflected in the import-side Herfindahl-Hirschman Index (HHI), which rose from 3,964 to 6,129 (+55%) — a level indicating a highly concentrated import structure and one that has become markedly more so over the decade.

2.3. EU member states' import profiles diverge sharply

Among EU member states, Germany and the Netherlands dominate the import side, together accounting for over three-quarters of extra-EU inflows:

The EU reporter breakdown shows that Germany's import growth (+1,229%) was by far the steepest among the major EU economies, consistent with its role as both a major healthcare market and a hub for device redistribution within the single market.

3. Export Diversification, Specialisation, and Supply-Chain Volatility

3.1. Exports diversified geographically while the United Kingdom emerged as the top destination

In contrast to the concentrating trend on the import side, EU exports became more geographically diversified: the export-side HHI fell from 1,429 to 1,095 (−23%). The United Kingdom overtook the United States as the single largest extra-EU export destination:

The explosive growth of exports to Saudi Arabia (+1,770%) and Japan (+1,188%) — two markets with significant healthcare infrastructure investment over this period — contributed to the declining export concentration. Export volatility was highest for the United Kingdom (CV = 0.98) and Canada (CV = 1.01), suggesting that these rapidly growing destinations still exhibit significant year-to-year variation.

3.2. Ireland, the Netherlands, and Germany anchor EU specialisation

Revealed-comparative-advantage analysis for 2025 identifies Ireland as the most specialised EU exporter in CN 90181990, with an RSCA of 0.56 and an RCA of 3.50, followed by the Netherlands (RSCA 0.47, RCA 2.79) and Germany (RSCA 0.26, RCA 1.70). These three countries collectively account for over 90% of the EU's extra-EU exports in this category. At the opposite end, Hungary, Slovakia, and Luxembourg show virtually no specialisation (RCA near zero), confirming that electro-diagnostic device manufacturing is concentrated in a handful of western European economies.

3.3. Rising import volatility from emerging suppliers poses a latent risk

While the volatility profiles of established partners such as Singapore (CV 0.28) and Israel (CV 0.21) remain moderate, several newer or smaller sources exhibit high variability:

Malaysia's exceptionally high CV (1.58) — the single most volatile import relationship in this dataset — combined with its rapid growth to €188 million, suggests that supply from this origin is still stabilising. Given the increasing share of non-US sources in EU imports, monitoring these volatility profiles is important for supply-chain resilience planning.

3.4. EU production scaled up substantially

Domestic production data shows the EU's output of electro-diagnostic apparatus (excluding the excluded sub-headings) rising from €2.0 billion to €4.0 billion in value (+98%) and from 3.4 million to 30 million items in quantity (+778%). The stark contrast between near-doubling of value and near-ninefold increase in quantity suggests a significant expansion of lower-unit-price device production — possibly connected to point-of-care and wearable diagnostic technologies — alongside continued production of traditional high-value systems.

Conclusion

The EU market for electro-diagnostic apparatus (CN 90181990) experienced a decade of exceptional growth between 2015 and 2025, with total extra-EU trade expanding from approximately €1.3 billion to over €6.7 billion. This expansion was powered by both rising volumes and increasing unit values, reflecting growing global demand for diagnostic technologies across neurology, cardiology rehabilitation, and functional medicine.

The most consequential structural change was the shift from near-balanced trade to a €764 million import deficit, driven overwhelmingly by surging imports from the United States. The EU's import-side concentration — now at an HHI of 6,129 with the US accounting for roughly 78% of inflows — represents a significant source of strategic dependence. On the export side, the EU succeeded in diversifying its destination markets, with particularly strong growth in the Middle East (Saudi Arabia) and Asia (Japan), while Ireland, the Netherlands, and Germany consolidated their positions as the EU's specialised exporters.

Looking ahead, the combination of rising import reliance, persistently volatile emerging-supplier relationships, and a doubling of domestic production capacity presents both challenges and opportunities. EU policymakers and industry stakeholders will need to monitor whether the production scale-up translates into stronger export competitiveness — and whether the growing trade deficit with the United States can be offset by further diversification of import sources.